The Bronx

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Hidradenitis suppurativa2 trials
• Lung cancer1 trial
• Schizophrenia1 trial

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Recruiting2 trials
• Completed1 trial
• Enrolling by invitation1 trial

Lead sponsor

• MoonLake Immunotherapeutics AG2 trials
• MapLight Therapeutics1 trial
• Summit Therapeutics1 trial

Running trials

• Recruiting

  A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

  NCT07459647· Phase 2· MapLight Therapeutics· Source

• Enrolling by invitation

  A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa

  NCT07007637· Phase 3· MoonLake Immunotherapeutics AG· Source

• Recruiting

  Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

  NCT06767514· Phase 3· Summit Therapeutics· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Hidradenitis suppurativa1 recruiting
• Lung cancer1 recruiting
• Schizophrenia1 recruiting

Closed trials

• Completed

  A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

  NCT06411899· Phase 3· MoonLake Immunotherapeutics AG· Source